COO - COOPER COMPANIES, INC.

83.37
-0.550   -0.660%

Share volume: 1,320,385
Last Updated: 03-03-2026
Medical Equipment/Ophthalmic Goods: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$83.92
-0.55
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.36%
1 Month
3.03%
3 Months
8.23%
6 Months
22.60%
1 Year
-8.05%
2 Year
-18.88%
Key data
Stock price
$83.37
P/E Ratio 
37.07
DAY RANGE
$81.26 - $83.98
EPS 
$1.73
52 WEEK RANGE
$61.78 - $91.59
52 WEEK CHANGE
-$8.72
MARKET CAP 
13.899 B
YIELD 
N/A
SHARES OUTSTANDING 
195.978 M
DIVIDEND
$0.03
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-27-2025
BETA 
0.42
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,775,378
AVERAGE 30 VOLUME 
$1,748,042
Company detail
CEO: Albert G. White
Region: US
Website: coopercos.com
Employees: 14,000
IPO year: 1983
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

CooperVision and CooperSurgical segments provide medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients. CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon.

Recent news